Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells

This protocol presents the use of SARS-CoV-2 isolates to infect human kidney organoids, enabling exploration of the impact of SARS-CoV-2 infection in a human multicellular in vitro system. We detail steps to generate kidney organoids from human pluripotent stem cells (hPSCs) and emulate a diabetic m...

Descripción completa

Detalles Bibliográficos
Autores principales: Garreta, Elena, Moya-Rull, Daniel, Stanifer, Megan L., Monteil, Vanessa, Prado, Patricia, Marco, Andrés, Tarantino, Carolina, Gallo, Maria, Jonsson, Gustav, Hagelkruys, Astrid, Mirazimi, Ali, Boulant, Steeve, Penninger, Josef M., Montserrat, Nuria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637521/
https://www.ncbi.nlm.nih.gov/pubmed/36595951
http://dx.doi.org/10.1016/j.xpro.2022.101872
Descripción
Sumario:This protocol presents the use of SARS-CoV-2 isolates to infect human kidney organoids, enabling exploration of the impact of SARS-CoV-2 infection in a human multicellular in vitro system. We detail steps to generate kidney organoids from human pluripotent stem cells (hPSCs) and emulate a diabetic milieu via organoids exposure to diabetogenic-like cell culture conditions. We further describe preparation and titration steps of SARS-CoV-2 virus stocks, their subsequent use to infect the kidney organoids, and assessment of the infection via immunofluorescence. For complete details on the use and execution of this protocol, please refer to Garreta et al. (2022).(1)

Ejemplares similares